Cargando…
Biological mesh is a safe and effective method of abdominal wall reconstruction in cytoreductive surgery for peritoneal malignancy
BACKGROUND: Patients with peritoneal malignancy often have multiple laparotomies before referral for cytoreductive surgery (CRS). Some have substantial abdominal wall herniation and tumour infiltration of abdominal incisions. CRS involves complete macroscopic tumour removal and hyperthermic intraper...
Autores principales: | Tzivanakis, A., Dayal, S. P., Arnold, S. J., Mohamed, F., Cecil, T. D., Venkatasubramaniam, A. K., Moran, B. J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254008/ https://www.ncbi.nlm.nih.gov/pubmed/30511047 http://dx.doi.org/10.1002/bjs5.93 |
Ejemplares similares
-
Do patients undergoing cytoreductive surgery and HIPEC for peritoneal malignancy need parenteral nutrition?
por: Swain, David R., et al.
Publicado: (2018) -
Outcomes of multicystic peritoneal mesothelioma treatment with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
por: Zahid, A, et al.
Publicado: (2020) -
Efficacy of fibrinogen concentrate in major abdominal surgery – A prospective, randomized, controlled study in cytoreductive surgery for pseudomyxoma peritonei
por: Roy, Ashok, et al.
Publicado: (2019) -
What is the evidence for the use of biologic or biosynthetic meshes in abdominal wall reconstruction?
por: Köckerling, F., et al.
Publicado: (2018) -
Clinical and surgical outcomes of patients with peritoneal mesothelioma discussed at a monthly national multidisciplinary team video‐conference meeting
por: Brandl, A., et al.
Publicado: (2020)